Collegium Pharmaceutical (COLL) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Collegium Pharmaceutical (COLL) over the last 8 years, with Q3 2025 value amounting to $16.1 million.
- Collegium Pharmaceutical's Long-Term Debt Repayments changed N/A to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 4409.72%. This contributed to the annual value of $107.8 million for FY2024, which is 3365.35% down from last year.
- As of Q3 2025, Collegium Pharmaceutical's Long-Term Debt Repayments stood at $16.1 million.
- Over the past 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments peaked at $138.6 million during Q1 2023, and registered a low of $12.5 million during Q1 2021.
- In the last 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments had a median value of $16.1 million in 2024 and averaged $29.9 million.
- In the last 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments surged by 115000.0% in 2021 and then crashed by 6694.05% in 2024.
- Over the past 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments (Quarter) stood at $12.5 million in 2021, then soared by 100.0% to $25.0 million in 2022, then dropped by 4.55% to $23.9 million in 2023, then plummeted by 32.34% to $16.1 million in 2024, then changed by 0.0% to $16.1 million in 2025.
- Its Long-Term Debt Repayments was $16.1 million in Q3 2025, compared to $16.1 million in Q2 2025 and $16.1 million in Q1 2025.